Intra Cellular Therapies shares owned by DCF Advisers
Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by DCF Advisers
from 13F filings
Historical chart of DCF Advisers investment in Intra Cellular Therapies
Tip: Access up to 7 years of quarterly data
All positions including Intra Cellular Therapies held by DCF Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Intra Cellular Therapies by DCF Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $5.6M | 107k | 52.09 |
| 2023-06-30 | $6.8M | 107k | 63.32 |
| 2023-03-31 | $6.4M | 119k | 54.15 |
| 2022-12-31 | $8.3M | 156k | 52.92 |
| 2022-09-30 | $7.7M | 166k | 46.53 |
| 2022-06-30 | $12M | 207k | 57.08 |
| 2022-03-31 | $15M | 239k | 61.19 |
| 2021-12-31 | $19M | 359k | 52.34 |
| 2021-09-30 | $14M | 379k | 37.28 |
| 2021-06-30 | $15M | 375k | 40.82 |
| 2021-03-31 | $14M | 425k | 33.93 |
| 2020-12-31 | $14M | 425k | 31.80 |
| 2020-09-30 | $11M | 427k | 25.66 |
| 2020-06-30 | $11M | 426k | 25.67 |
| 2020-03-31 | $6.6M | 433k | 15.37 |
| 2019-12-31 | $16M | 468k | 34.31 |